Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
RIGL
— Rigel Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2025 Earnings Call Summary
NOV 4, 2025
REVENUE
$69.5M
-31.7%
NET MARGIN
40.2%
-18.5 PTS
EPS
$1.55
-53.5%
FREE CASH FLOW
$24.0M
-21.3%
No summary has been written for this call yet.
← NEWER CALL
CALL 4 OF 4
OLDER CALL →